Sandoz Looks Ahead To Biosimilar Opportunities
Sees Upside From Aurobindo Deal Collapse; Canada Growth To Outpace US
Sandoz sees key opportunities ahead in both the US and Canadian biosimilars markets, the firm’s US vice-president for marketing, market access and patient services, Sheila Frame, tells Generics Bulletin in the second part of an exclusive interview.
